Corvus Pharmaceuticals (CRVS) EPS (Basic) (2015 - 2026)
Corvus Pharmaceuticals (CRVS) recorded quarterly EPS (Basic) of -$0.15 in Q1 2026, little changed quarter-over-quarter from -$0.15 in Q4 2025, and down 171.43% on a YoY basis from $0.21 in Q1 2025.
Corvus Pharmaceuticals (CRVS) EPS (Basic) (2015 - 2026) Analysis & Trends
Corvus Pharmaceuticals' EPS (Basic) history runs 12 years deep, the most recent figure standing at -$0.15 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 171.43% year-over-year to -$0.15; the TTM figure through Mar 2026 stood at -$0.52 (up 16.13% YoY), while the FY2025 annual figure was -$0.19, up 81.37% from the prior year.
- EPS (Basic) was -$0.15 for Q1 2026 at Corvus Pharmaceuticals, roughly flat from -$0.15 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.21 in Q1 2025 to a low of -$0.6 in Q3 2024.
- Historically, EPS (Basic) has averaged -$0.16 across 5 years, with a median of -$0.15 in 2025.
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) tumbled 400.0% in 2024, then surged 275.0% in 2025.
- A 5-year view of EPS (Basic) shows it stood at -$0.21 in 2022, then jumped by 38.1% to -$0.13 in 2023, then slipped by 23.08% to -$0.16 in 2024, then climbed by 6.25% to -$0.15 in 2025, then changed by 0.0% to -$0.15 in 2026.
- The last three EPS (Basic) figures came in at -$0.15 (Q1 2026), -$0.15 (Q4 2025), and -$0.12 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 0.00 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 0.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -0.06 |
| 10 | Corvus Pharmaceuticals | 1.00 Bn | 766.75 Mn | - | -0.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.15 |
| Dec 31, 2025 | -0.15 |
| Sep 30, 2025 | -0.12 |
| Jun 30, 2025 | -0.10 |
| Mar 31, 2025 | 0.21 |
| Dec 31, 2024 | -0.16 |
| Sep 30, 2024 | -0.60 |
| Jun 30, 2024 | -0.07 |
| Mar 31, 2024 | -0.12 |
| Dec 31, 2023 | -0.13 |
| Sep 30, 2023 | -0.12 |
| Jun 30, 2023 | -0.14 |
| Mar 31, 2023 | -0.17 |
| Dec 31, 2022 | -0.21 |
| Sep 30, 2022 | -0.32 |
| Jun 30, 2022 | -0.18 |
| Mar 31, 2022 | -0.18 |
| Dec 31, 2021 | -0.20 |
| Sep 30, 2021 | -0.24 |
| Jun 30, 2021 | -0.28 |